UNSPSC 85673611: Supplement left hand bursa and ligament with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left hand bursa and ligament with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0MU847Z

UNSPSC 85673611 Supplement left hand bursa and ligament with autologous tissue substitute, percutaneous endoscopic approach (Commodity) does not align with recent state and local procurement activity. The code nominally describes a specific orthopedic surgical procedure using tissue substitution, yet the six recent opportunities posted across state and local jurisdictions between July and September 2026 procure medical administration, surveillance, staffing, and benefit management services—none of which involve surgical instrumentation, tissue products, or procedure-specific medical supplies. The City of Phoenix Retirement Office solicited independent medical evaluation services for disability determinations; the Washington State Department of Transportation sought occupational medical surveillance; Collier County issued an RFP for pharmacy benefit management; the County of Santa Clara Health System established a qualified vendor pool for temporary health professional staffing; and the City of Long Beach and Harris County Juvenile Probation Department each posted opportunities for broader medical and surgical benefit administration rather than implant or surgical-supply procurement.

State and local buyers do not appear to use this code for actual medical device or tissue-substitute procurement. The code's placement in the taxonomy suggests it targets manufacturers or distributors of biological or synthetic graft materials, instrumentation, or related medical supplies—a market segment absent from the recent opportunities block. Without evidence of active state or local solicitation under this specific commodity code, pursuing this category would require validation of whether public-sector buyers classify orthopedic implant and tissue-substitute procurement under this code at all, or whether they route such spend through different taxonomy branches, group purchasing agreements, or healthcare system GPO arrangements not reflected in posted public notices.